Literature DB >> 21987211

[Epidemiology of prostate cancer].

N Becker1.   

Abstract

Since a number of years, prostate cancer has been the most frequent cancer site among men in Germany and has replaced lung cancer as the leading position. Among the most frequent cancer sites, it is the one with the lowest available knowledge about etiology. Smoking and alcohol apparently do not play a role. Regarding food intake, indications exist for a protective association to tomatoes or lycopene consumption and a protective association was also seen with high physical activity, while risk seems to be elevated in obese men. Associations to hormonal factors have been observed and are under consideration. Trials with potential chemopreventive agents have been unsuccessful so far. For early detection, digital rectal examination has been part of the German statutory early detection program" from the very beginning in 1971 and the test for prostate specific antigen (PSA) is being used in the framework of the so-called individual health services, both without scientific evidence of effectiveness. The available data show that the progression of prostate cancer to the leading male cancer site was chiefly driven by the unstructured introduction of the PSA test as a screening tool. Cynically addressed, the figures indicate that the most efficient known preventive intervention was not to attend screening. This delicate situation should, however, not discourage from further examinations of prostate cancer screening. Recent results including the European randomized prostate cancer screening study (ERSPC) indicated that intelligently structured screening, possibly even using the PSA test, might be effective. Before routine application the novel approaches also have to be scrutinized in a research setting.

Entities:  

Mesh:

Year:  2011        PMID: 21987211     DOI: 10.1007/s00117-011-2183-1

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  40 in total

1.  Cancer, genes, and the environment.

Authors:  R Peto
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

2.  Plasma selenium concentration and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Naomi E Allen; Paul N Appleby; Andrew W Roddam; Anne Tjønneland; Nina Føns Johnsen; Kim Overvad; Heiner Boeing; Steffen Weikert; Rudolf Kaaks; Jakob Linseisen; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Carlotta Sacerdote; Sara Grioni; Domenico Palli; Rosario Tumino; H Bas Bueno-de-Mesquita; Lambertus A Kiemeney; Aurelio Barricarte; Nerea Larrañaga; Maria-José Sánchez; Antonio Agudo; María-José Tormo; Laudina Rodriguez; Pär Stattin; Göran Hallmans; Sheila Bingham; Kay-Tee Khaw; Nadia Slimani; Sabina Rinaldi; Paolo Boffetta; Elio Riboli; Timothy J Key
Journal:  Am J Clin Nutr       Date:  2008-12       Impact factor: 7.045

3.  Prostate cancer incidence and mortality trends in 37 European countries: an overview.

Authors:  F Bray; J Lortet-Tieulent; J Ferlay; D Forman; A Auvinen
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

4.  Interval cancers in the Antwerp European randomised study of screening for prostate cancer study, using a 6 year screening interval.

Authors:  Vera Nelen; Guy Thys; Annemie Hermans; Kristien D'Hooge; Brigitte Dourcy-Belle-Rose; Jan-Willem Coebergh; Monique Roobol; Louis Denis
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

5.  On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.

Authors:  Chris H Bangma; Ron H van Schaik; Bert G Blijenberg; Monique J Roobol; Hans Lilja; Ulf-Håkan Stenman
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

6.  Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.

Authors:  Siobhan Sutcliffe; Raphael P Viscidi; Cathee Till; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; Angelo M De Marzo; Elizabeth A Platz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

7.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

8.  The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Authors:  J K Gohagan; P C Prorok; R B Hayes; B S Kramer
Journal:  Control Clin Trials       Date:  2000-12

9.  Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Timothy J Key; Naomi Allen; Paul Appleby; Kim Overvad; Anne Tjønneland; Anthony Miller; Heiner Boeing; Dimitrios Karalis; Theodora Psaltopoulou; Franco Berrino; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-De-Mesquita; Lambertus Kiemeney; Petra H M Peeters; Carmen Martinez; Miren Dorronsoro; Carlos A González; M D Chirlaque; J Ramon Quiros; Eva Ardanaz; Göran Berglund; Lars Egevad; Göran Hallmans; Pär Stattin; Sheila Bingham; Nicholas Day; Peter Gann; Rudolf Kaaks; Pietro Ferrari; Elio Riboli
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

10.  Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition.

Authors:  Tobias Pischon; Heiner Boeing; Steffen Weikert; Naomi Allen; Tim Key; Nina Føns Johnsen; Anne Tjønneland; Marianne Tang Severinsen; Kim Overvad; Sabine Rohrmann; Rudolf Kaaks; Antonia Trichopoulou; Gitaki Zoi; Dimitrios Trichopoulos; Valeria Pala; Domenico Palli; Rosario Tumino; Carlotta Sacerdote; H Bas Bueno-de-Mesquita; Anne May; Jonas Manjer; Peter Wallström; Pär Stattin; Göran Hallmans; Genevieve Buckland; Nerea Larrañaga; María Dolores Chirlaque; Carmen Martínez; María L Redondo Cornejo; Eva Ardanaz; Sheila Bingham; Kay-Tee Khaw; Sabina Rinaldi; Nadia Slimani; Mazda Jenab; Elio Riboli
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more
  2 in total

1.  The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.

Authors:  Chenying Fu; Wen-Qi Dong; Ani Wang; Guozhen Qiu
Journal:  Tumour Biol       Date:  2014-05-24

Review 2.  ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis.

Authors:  Yu-Mei Wang; Zu-Wang Liu; Jing-Bo Guo; Xiao-Fang Wang; Xin-Xin Zhao; Xuan Zheng
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.